Eversept Partners, LP
- SEC CIK
- 0001697013
- 最新申報
- 2026/8/14
2024 年第 3 季持倉
持倉截至 2024/9/30，2024/11/14 申報。只含多頭部位，變化是跟 2024 年第 2 季比股數。
- 持股檔數
- 65
- 較 2024 年第 2 季 −7
- 總值
- $13.0 億
- 較 2024 年第 2 季 −$309.2 萬 (−0.2%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| GSKGSK plc | ADR | 4,057,206 | $1.66 億 | 12.7% | +589,126+17.0% | 加碼 | 歷史 |
| NTRANatera, Inc. | COM | 870,193 | $1.10 億 | 8.5% | −303,301−25.8% | 減碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 2,050,157 | $9,062 萬 | 7.0% | +6,943+0.3% | 加碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 1,089,404 | $7,953 萬 | 6.1% | −66,184−5.7% | 減碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 4,105,313 | $7,903 萬 | 6.1% | +491,682+13.6% | 加碼 | 歷史 |
| RVTYRevvity, Inc. | COM | 469,692 | $6,000 萬 | 4.6% | +18,110+4.0% | 加碼 | 歷史 |
| INSPInspire Medical Systems, Inc. | COM | 276,270 | $5,831 萬 | 4.5% | −256,741−48.2% | 減碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 3,234,638 | $5,829 萬 | 4.5% | −1,485,822−31.5% | 減碼 | 歷史 |
| CYHCommunity Health Systems Inc | COM | 8,776,455 | $5,327 萬 | 4.1% | +738,985+9.2% | 加碼 | 歷史 |
| TECHBIO-TECHNE Corp | COM | 663,573 | $5,304 萬 | 4.1% | +120,529+22.2% | 加碼 | 歷史 |
| HCAHCA Healthcare, Inc. | COM | 129,084 | $5,246 萬 | 4.0% | −6,396−4.7% | 減碼 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 130,949 | $4,693 萬 | 3.6% | −104,402−44.4% | 減碼 | 歷史 |
| ZIMVZimVie Inc. | Stock | 2,070,780 | $3,286 萬 | 2.5% | +1,303,121+169.8% | 加碼 | 歷史 |
| HQYHealthequity, Inc. | COM | 319,078 | $2,612 萬 | 2.0% | −94,453−22.8% | 減碼 | 歷史 |
| RGENRepligen Corp | COM | 163,593 | $2,435 萬 | 1.9% | −30,698−15.8% | 減碼 | 歷史 |
| VTRSViatris Inc | Stock | 1,726,354 | $2,004 萬 | 1.5% | +397,072+29.9% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 445,204 | $2,003 萬 | 1.5% | −60,632−12.0% | 減碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 564,902 | $1,920 萬 | 1.5% | −68,113−10.8% | 減碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 471,355 | $1,888 萬 | 1.4% | +14,474+3.2% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 691,232 | $1,573 萬 | 1.2% | +123,745+21.8% | 加碼 | 歷史 |
| MNKDMannkind Corp | COM NEW | 1,992,504 | $1,253 萬 | 1.0% | −264,448−11.7% | 減碼 | 歷史 |
| BHCBausch Health Companies Inc. | Stock | 1,530,914 | $1,249 萬 | 1.0% | +1,530,914 | 新進 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 869,913 | $1,217 萬 | 0.9% | −221,252−20.3% | 減碼 | 歷史 |
| HUMHumana Inc | Stock | 33,860 | $1,072 萬 | 0.8% | −4,163−10.9% | 減碼 | 歷史 |
| DHRDanaher Corp | Stock | 38,429 | $1,068 萬 | 0.8% | −2,426−5.9% | 減碼 | 歷史 |
| CNCCentene Corp | Stock | 134,959 | $1,016 萬 | 0.8% | +19,139+16.5% | 加碼 | 歷史 |
| ELVElevance Health, Inc. | Stock | 19,465 | $1,012 萬 | 0.8% | +4,808+32.8% | 加碼 | 歷史 |
| FTREFortrea Holdings Inc. | COMMON STOCK | 457,967 | $915.9 萬 | 0.7% | +457,967 | 新進 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 124,491 | $910.9 萬 | 0.7% | +124,491 | 新進 | 歷史 |
| EOLSEvolus, Inc. | COM | 453,061 | $734.0 萬 | 0.6% | −121,401−21.1% | 減碼 | 歷史 |
| BHVNBiohaven Ltd. | COM | 132,537 | $662.3 萬 | 0.5% | +132,537 | 新進 | 歷史 |
| ARQTArcutis Biotherapeutics, Inc. | COM | 693,263 | $644.7 萬 | 0.5% | −144,584−17.3% | 減碼 | 歷史 |
| STROSutro Biopharma, Inc. | COM | 1,841,989 | $637.3 萬 | 0.5% | +102,860+5.9% | 加碼 | 歷史 |
| BKDBrookdale Senior Living Inc. | COM | 861,268 | $584.8 萬 | 0.4% | −685,574−44.3% | 減碼 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 307,357 | $510.2 萬 | 0.4% | −22,533−6.8% | 減碼 | 歷史 |
| FNAParagon 28, Inc. | COM | 749,213 | $500.5 萬 | 0.4% | +749,213 | 新進 | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 4,978,458 | $491.1 萬 | 0.4% | −505,690−9.2% | 減碼 | 歷史 |
| TSVT2seventy bio, Inc. | COMMON STOCK | 998,079 | $471.1 萬 | 0.4% | −109,664−9.9% | 減碼 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM | 5,547,880 | $460.5 萬 | 0.4% | +560,700+11.2% | 加碼 | 歷史 |
| AVTRAvantor, Inc. | COM | 168,369 | $435.6 萬 | 0.3% | +42,975+34.3% | 加碼 | 歷史 |
| BCRXBiocryst Pharmaceuticals Inc | COM | 535,405 | $406.9 萬 | 0.3% | −617,168−53.5% | 減碼 | 歷史 |
| ICLRIcon PLC | COM | 13,668 | $392.7 萬 | 0.3% | +1,026+8.1% | 加碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 192,398 | $375.9 萬 | 0.3% | +120,081+166.0% | 加碼 | 歷史 |
| MOHMolina Healthcare, Inc. | COM | 10,588 | $364.8 萬 | 0.3% | −7,689−42.1% | 減碼 | 歷史 |
| MRUSMerus N.V. | COM | 68,258 | $341.0 萬 | 0.3% | +1,784+2.7% | 加碼 | 歷史 |
| STAAStaar Surgical Co | COM PAR $0.01 | 91,199 | $338.8 萬 | 0.3% | +91,199 | 新進 | 歷史 |
| PBYIPuma Biotechnology, Inc. | COM | 1,293,257 | $329.8 萬 | 0.3% | −35,197−2.6% | 減碼 | 歷史 |
| ZLABZai Lab Ltd | ADR | 135,219 | $326.4 萬 | 0.3% | +135,219 | 新進 | 歷史 |
| ZBIOZenas BioPharma, Inc. | COM | 190,531 | $322.4 萬 | 0.2% | +190,531 | 新進 | 歷史 |
| MREOMereo BioPharma Group plc | SPON ADS | 777,890 | $319.7 萬 | 0.2% | +281,719+56.8% | 加碼 | 歷史 |
| IQVIQVIA Holdings Inc. | Stock | 13,138 | $311.3 萬 | 0.2% | +960+7.9% | 加碼 | 歷史 |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 336,966 | $280.0 萬 | 0.2% | +336,966 | 新進 | 歷史 |
| XOMAXOMA Royalty Corp | COM NEW | 94,289 | $249.7 萬 | 0.2% | +2,382+2.6% | 加碼 | 歷史 |
| IFRXInflaRx N.V. | COM | 1,621,787 | $248.1 萬 | 0.2% | +54,857+3.5% | 加碼 | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 84,380 | $216.9 萬 | 0.2% | −120,401−58.8% | 減碼 | 歷史 |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 3,309,309 | $207.5 萬 | 0.2% | −999,218−23.2% | 減碼 | 歷史 |
| NVRONevro Corp | COM | 313,780 | $175.4 萬 | 0.1% | −185,615−37.2% | 減碼 | 歷史 |
| ALECAlector, Inc. | COM | 332,756 | $155.1 萬 | 0.1% | −208,983−38.6% | 減碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 406,558 | $147.6 萬 | 0.1% | −204,344−33.4% | 減碼 | 歷史 |
| LQDALiquidia Corp | COM NEW | 137,949 | $137.9 萬 | 0.1% | −235,605−63.1% | 減碼 | 歷史 |
| ABSIAbsci Corp | COM | 272,869 | $104.2 萬 | 0.1% | −52,640−16.2% | 減碼 | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 485,141 | $101.4 萬 | 0.1% | +485,141 | 新進 | 歷史 |
| STOKStoke Therapeutics, Inc. | COM | 52,006 | $63.9 萬 | <0.1% | −9,271−15.1% | 減碼 | 歷史 |
| Affimed N VN01045207 | ORDINARY SHS NEW | 166,460 | $55.9 萬 | <0.1% | 00.0% | 不變 | – |
| ACIUAC Immune SA | SHS | 99,313 | $37.5 萬 | <0.1% | 00.0% | 不變 | 歷史 |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| Invesco QQQ Trust Series I46090E103 | ETF | $1.22 億 | – |
| SPYSPDR S&P 500 ETF Trust | ETF | $3,443 萬 | – |
2024 年第 2 季之後清倉（17 檔）
2024 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 2 季股數 | 2024 年第 2 季市值 | 2024 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| NVONovo Nordisk A S | ADR | 146,956 | $2,098 萬 | 1.6% | 歷史 |
| LLYEli Lilly & Co | Stock | 21,233 | $1,922 萬 | 1.5% | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 34,593 | $1,488 萬 | 1.1% | 歷史 |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 100,000 | $927.1 萬 | 0.7% | – |
| VKTXViking Therapeutics, Inc. | COM | 138,489 | $734.1 萬 | 0.6% | 歷史 |
| PCVXVaxcyte, Inc. | COM | 96,089 | $725.6 萬 | 0.6% | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 126,877 | $687.4 萬 | 0.5% | 歷史 |
| OSCROscar Health, Inc. | CL A | 310,893 | $491.8 萬 | 0.4% | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 110,010 | $449.8 萬 | 0.3% | 歷史 |
| MYGNMyriad Genetics Inc | COM | 181,961 | $445.1 萬 | 0.3% | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 71,596 | $314.8 萬 | 0.2% | 歷史 |
| GHGuardant Health, Inc. | COM | 99,377 | $287.0 萬 | 0.2% | 歷史 |
| IMVTImmunovant, Inc. | COM | 92,909 | $245.3 萬 | 0.2% | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 286,266 | $194.9 萬 | 0.1% | 歷史 |
| FULCFulcrum Therapeutics, Inc. | COM | 152,965 | $94.8 萬 | 0.1% | 歷史 |
| GTHXG1 Therapeutics, Inc. | COM | 199,963 | $45.6 萬 | <0.1% | 歷史 |
| MCRBSeres Therapeutics, Inc. | COM | 418,208 | $30.3 萬 | <0.1% | 歷史 |